Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04687761
Title Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications

acute myeloid leukemia

Therapies

Cytarabine + Quizartinib + Venetoclax

Azacitidine + Quizartinib + Venetoclax

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.